Tech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HitIQ.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Emyria to create wearable device for psychedelics, while Telix gets FDA nod
News
10 at 10: These ASX stocks are a beacon of hope this morning
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Tech
HITIQ fast-tracks growth plans with NZ concussion tech platform takeover
Health & Biotech
ASX Health: Twiggy Forrest’s investment fund takes a stake in this ASX cannabis stock
Tech
HITIQ lands another global strategic collaboration in new deal with Scottish Rugby, shares jump
Tech
HITIQ shares soar almost 10% on US college football deal
Health & Biotech
Health Kick Podcast: HitIQ has a revolutionary solution for the concussion problem in contact sports
Tech
HitIQ signs landmark Bupa Dental deal for junior rugby concussion trial
Health & Biotech
ASX health stocks: HitIQ leaps 5% after deal to trial junior rugby players with concussion technology
Health & Biotech
These two ASX brain health stocks, boosted by FDA’s approval of Adulhelm, are kicking off clinical trials
News
ASX Capital Raise Roundup: Who’s ready to ride the risk/reward roundabout this week?
Tech
The sports data economy is growing fast – can ASX players get in the game?
Health & Biotech
As neuroscience blurs the line between tech and biology, these ASX brain health stocks are on the frontline
News
Last Orders: ASX teeters on the edge of 7,400
Tech
IPO Watch: HitIQ hits the ground running with a 30pc gain on debut
Tech